Lifeward has named Mark Grant as the company’s new president and CEO. Grant will take office on June 2.

Departing CEO Larry Jasinski will serve as co-CEO and as previously announced will serve in an advisory role until the end of June, and thereafter on an as-needed basis through the end of 2025.

“Mark brings 30 years of combined experience in commercial leadership, channel development and strategic solutions, and is the perfect choice to lead Lifeward in its next stage of growth,” said Joseph Turk, chairman of Lifeward’s board. “As a leader, Mark has managed teams in multiple geographies and has led critical functions, including Americas field and inside sales, field clinicians, managed markets, sales channels, health economics and reimbursement, sales training and enablement, revenue cycle management, marketing, and global customer service.”

“I want to welcome Mark on behalf of the entire Lifeward Board; we look forward to working with him to help drive innovations that change the lives of individuals with physical limitations, impairments, or disabilities, including spinal cord injuries,” Turk went on. “I also want to thank Larry for his unwavering commitment to Lifeward over the years, and for his valued support in facilitating a seamless leadership transition.”

Grant had several leadership roles at Medtronic from 2004 to 2023, rising to VP for the Americas. His responsibilities and achievements included directing development and execution of strategies to deliver annual revenue targets in the highly competitive diabetic home care market, opening commercial markets by establishing access to new direct-payer constituencies, including the U.S. Department of Veterans Affairs, optimizing revenue cycle operations, identifying and pursuing new business opportunities based on market trends and competitor research, and restructuring the business to meet changing operational demands.

Before joining Lifeward, Grant was president of Americas and chief commercial officer of IMRA Surgical, a company specializing in ethical surgical training solutions. Before joining Medtronic, Grant has roles at Bristol Myers Squibb and FLA Orthopedics.

“I’m thrilled and honored to be joining the Lifeward team at such an exciting time in its history,” said Grant. “In the last year, the company has taken great strides, including the major milestone of achieving Medicare payment for the ReWalk exoskeleton while building a robust pipeline of ReWalk cases.ReWalk is representative of Lifeward’s robust portfolio of life-changing, breakthrough solutions, which are based on the Company’s wealth of technical expertise, R&D capabilities, and patented robotics technology. As CEO, I look forward to helping Lifeward leverage its many strengths to achieve balanced and sustainable growth as we establish a strong foundation for the future and work strategically toward profitability.”

Last month, the company released its ReWalk 7 personal exoskeleton in the U.S. ReWalk 7 includes new and enhanced features like cloud connectivity and customizable walking speeds.

“Furthermore, I look forward to working with our valued partners in the patient advocacy community who share Lifeward’s profound commitment to improving the quality of life of the patients we have the honor of serving,” Grant went on.